These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 30701938)
1. Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program "odyssey". Maev IV; Kucheravy YA; Tsukanov VV; Eremnia EY; Andreev DN; Abdulhakov SR; Akhmedov VA; Batskov SS; Vasyutin AV; V'yuchnova ES; Ivanchenko DN; Luzina EV; Krapivnaya OV; Onuchina EV; Osipenko MF; Simanenkov VI; Tonkih YL; Khomeriki NM; Shklyaev AE; Akimov AV; Sokolov KA Ter Arkh; 2018 Aug; 90(8):40-47. PubMed ID: 30701938 [TBL] [Abstract][Full Text] [Related]
2. A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome. Van Outryve M; Mayeur S; Meeus MA; Rosillon D; Hendrickx B; Ceuppens M J Clin Pharm Ther; 1995 Oct; 20(5):277-82. PubMed ID: 8576295 [TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of duspatalin therapy in the treatment and prevention of post-cholecystectomy syndrome]. Lipnitskiĭ EM; Isakova OV; Movchun VA; Apdatskaia MD Vestn Ross Akad Med Nauk; 2011; (1):7-11. PubMed ID: 21395089 [TBL] [Abstract][Full Text] [Related]
5. Mebeverine for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Pourmoghaddas Z; Saneian H; Roohafza H; Gholamrezaei A Biomed Res Int; 2014; 2014():191026. PubMed ID: 25089264 [TBL] [Abstract][Full Text] [Related]
6. [Assessment of the efficacy of mebeverine in the complex therapy of chronic noncalculolis cholecystitis and biliary dysfunction]. Maev IV; Samsonov AA; Ul'iankina EV; Nikushkina IN; Salova LM; Shakh IuS Eksp Klin Gastroenterol; 2007; (2):120-5. PubMed ID: 17539356 [No Abstract] [Full Text] [Related]
7. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients. Jones RH; Holtmann G; Rodrigo L; Ehsanullah RS; Crompton PM; Jacques LA; Mills JG Aliment Pharmacol Ther; 1999 Nov; 13(11):1419-27. PubMed ID: 10571597 [TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. El-Haggar SM; Hegazy SK; Abd-Elsalam SM; Bahaa MM Biomed Pharmacother; 2022 Jan; 145():112399. PubMed ID: 34775240 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of duspatalin in the treatment and prophylaxis of postcholecystectomic syndrome]. Lipnitskiĭ EM; Isakova OV; Dzhadzhanidze AD; Ardatskaia MD Eksp Klin Gastroenterol; 2008; (3):86-93. PubMed ID: 19145887 [No Abstract] [Full Text] [Related]
10. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study. Chapman ND; Grillage MG; Mazumder R; Atkinson SN Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997 [TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind study of mebeverine versus dicyclomine in the treatment of functional abdominal pain in young adults. Grillage MG; Nankani JN; Atkinson SN; Prescott P Br J Clin Pract; 1990 May; 44(5):176-9. PubMed ID: 2202405 [No Abstract] [Full Text] [Related]
12. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. Lee KJ; Kim NY; Kwon JK; Huh KC; Lee OY; Lee JS; Choi SC; Sohn CI; Myung SJ; Park HJ; Choi MK; Bak YT; Rhee PL Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001 [TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of trimebutine versus mebeverine in the treatment of irritable bowel syndrome. Rahman MZ; Ahmed DS; Mahmuduzzaman M; Rahman MA; Chowdhury MS; Barua R; Ishaque SM Mymensingh Med J; 2014 Jan; 23(1):105-13. PubMed ID: 24584382 [TBL] [Abstract][Full Text] [Related]
14. Oral mebeverine in barium enema preparation. Messios N; Shaker M; Berry JM Clin Radiol; 1982 May; 33(3):271-2. PubMed ID: 7042177 [TBL] [Abstract][Full Text] [Related]
15. Mebeverine alters small bowel motility in irritable bowel syndrome. Evans PR; Bak YT; Kellow JE Aliment Pharmacol Ther; 1996 Oct; 10(5):787-93. PubMed ID: 8899088 [TBL] [Abstract][Full Text] [Related]
16. [Duspatalin in functional disorders of the Oddi's sphincter in patients subjected cholecystectomy]. Il'chenko AA; Bystrovskaia EV Eksp Klin Gastroenterol; 2002; (4):21-2, 130. PubMed ID: 12503268 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. Darvish-Damavandi M; Nikfar S; Abdollahi M World J Gastroenterol; 2010 Feb; 16(5):547-53. PubMed ID: 20128021 [TBL] [Abstract][Full Text] [Related]
18. Mebeverine decreases mass movements and stool frequency in lactulose-induced diarrhoea. Washington N; Ridley P; Thomas C; Spiller RC; Watts PJ; Wilson CG Aliment Pharmacol Ther; 1998 Jun; 12(6):583-8. PubMed ID: 9678820 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome. Gilbody JS; Fletcher CP; Hughes IW; Kidman SP Int J Clin Pract; 2000 Sep; 54(7):461-4. PubMed ID: 11070572 [TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study. Goettsch WG; van den Boom G; Breekveldt-Postma NS; Smout AJ; Herings RM Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):803-10. PubMed ID: 15386693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]